Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistocytosis provides therapeutic guidance

British Journal of Haematology

Volumn 129, Issue 5, 2005, Pages 658-666

  Horne, AnnaCarin ^a   Zheng, Chengyun ^a   Lorenz, Ingrid ^b   Löfstedt, Martina ^a   Montgomery, Scott M ^a   Janka, Gritta ^c   Henter, Jan Inge ^a   Schneider, E Marion ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cytotoxicity; Haemophagocytic lymphohistiocytosis; Natural killer cells; Stem cell transplantation; Survival

Indexed keywords

PERFORIN;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL CYTOTOXICITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFECT; REMISSION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INFANT; KILLER CELLS, NATURAL; MALE; PATIENT SELECTION; REMISSION INDUCTION; STATISTICS, NONPARAMETRIC; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 20444455073     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05502.x     Document Type: Article

References (37)

1. Arico, M., Janka, G., Fischer, A., Henter, J.I., Blanche, S., Elinder, G., Martinetti, M. & Rusca, M.P. (1996) Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia, 10, 197-203.
2. Clementi, R., zur Stadt, U., Savoldi, G., Varoitto, S., Conter, V., De Fusco, C., Notarangelo, L.D., Schneider, M., Klersy, C., Janka, G., Danesino, C. & Arico, M. (2001) Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 38, 643-646.
3. Egeler, R.M., Shapiro, R., Loechelt, B. & Filipovich, A. (1996) Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology Oncology, 18, 340-345.
4. Emminger, W., Zlabinger, G.J., Fritsch, G. & Urbanek, R. (2001) CD14(dim)/CD16(bright) monocytes in hemophagocytic lymphohistiocytosis. European Journal of Immunology, 31, 1716-1719.
5. Esumi, N., Ikushima, S., Todo, S. & Imashuku, S. (1989) Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases. Acta Paediatrica Scandinavica, 78, 268-270.
6. Fadeel, B., Orrenius, S. & Henter, J.I. (1999) Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. British Journal of Haematology, 106, 406-415.
7. Fadeel, B., Orrenius, S. & Henter, J.I. (2001) Familial hemophagocytic lymphohistiocytosis: too little cell death can seriously damage your health. Leukemia and Lymphoma, 42, 13-20.
8. Feldmann, J., Le Deist, F., Ouachee-Chardin, M., Certain, S., Alexander, S., Quartier, P., Haddad, E., Wulffraat, N., Casanova, J.L., Blanche, S., Fischer, A. & de Saint Basile, G. (2002) Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. British Journal of Haematology, 117, 965-972.
9. Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., Lambert, N., Ouachee-Chardin, M., Chedeville, G., Tamary, H., Minard-Colin, V., Vilmer, E., Blanche, S., Le Deist, F., Fischer, A. & de Saint Basile, G. (2003) Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell, 115, 461-473.
10. Gagnaire, M.H., Galambrun, C. & Stephan, J.L. (2000) Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children - a series of 12 cases. Pediatrics, 106, E58.
11. Goransdotter Ericson, K., Fadeel, B., Nilsson-Ardnor, S., Soderhall, C., Samuelsson, A., Janka, G., Schneider, M., Gurgey, A., Yalman, N., Revesz, T., Egeler, R., Jahnukainen, K., Storm-Mathiesen, I., Haraldsson, A., Poole, J., de Saint Basile, G., Nordenskjold, M. & Henter, J.I. (2001) Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. American Journal of Human Genetics, 68, 590-597.
12. Hasegawa, D., Kojima, S., Tatsumi, E., Hayakawa, A., Kosaka, Y., Nakamura, H., Sako, M., Osugi, Y., Nagata, S. & Sano, K. (1998) Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood, 91, 2793-2799.
13. Henter, J.I., Elinder, G. & Ost, A. (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Seminars in Oncology, 18, 29-33.
14. Henter, J.I., Ehrnst, A., Andersson, J. & Elinder, G. (1993) Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatrica, 82, 369-372.
15. Henter, J.I., Arico, M., Elinder, G., Imashuku, S. & Janka, G. (1998) Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematology/Oncology Clinics of North America, 12, 417-433.
16. Henter, J.I., Samuelsson-Horne, A., Arico, M., Egeler, R.M., Elinder, G., Filipovich, A.H., Gadner, H., Imashuku, S., Komp, D., Ladisch, S., Webb, D. & Janka, G. (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 100, 2367-2373.
17. Horne, A., Janka, G., Egeler, R.M., Gadner, H., Imashuku, S., Janka, G., Ladisch, S., Locatelli, F., Montgomery, S.M., Webb, D., Winiarski, J., Filipovich, A.H. & Henter, J.I., (2005) Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. British Journal of Haematology, 129, (5).
18. Imashuku, S., Kuriyama, K., Teramura, T., Ishii, E., Kinugawa, N., Kato, M., Sako, M. & Hibi, S. (2001) Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Clinical Oncology, 19, 2665-2673.
19. Imashuku, S., Hyakuna, N., Funabiki, T., Ikuta, K., Sako, M., Iwai, A., Fukushima, T., Kataoka, S., Yabe, M., Muramatsu, K., Kohdera, U., Nakadate, H., Kitazawa, K., Toyoda, Y. & Ishii, E. (2002) Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis. Cancer, 94, 3023-3031.
20. Ishii, E., Ueda, I., Shirakawa, R., Yamamoto, K., Horiuchi, H., Ohga, S., Furuno, K., Morimoto, A., Imayoshi, M., Ogata, Y., Zaitzu, M., Sako, M., Koike, K., Sakata, A., Takada, H., Hara, T., Imashuku, S., Sasazuki, T. & Yasukawa, M. (2005) Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood, 105, (9).
21. Janka, G.E. (1983) Familial hemophagocytic lymphohistiocytosis. European Journal of Pediatrics, 140, 221-230.
22. Jordan, M.B., Hildeman, D., Kappler, J. & Marrack, P. (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood, 104, 735-743.
23. Kogawa, K., Lee, S.M., Villanueva, J., Marmer, D., Sumegi, J. & Filipovich, A.H. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood, 99, 61-66.
24. Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmire, J.K., Walsh, C.M., Clark, W.R. & Ahmed, R. (1999) A role for perforin in downregulating T-cell responses during chronic viral infection. Journal of Virology, 73, 2527-2536.
25. Moretta, L., Bottino, C., Cantoni, C., Mingari, M.C. & Moretta, A. (2001) Human natural killer cell function and receptors. Current Opinion in Pharmacology, 1, 387-391.
26. Podack, E.R. (1995) Perforin, killer cells and gene transfer immunotherapy for cancer. Current Topics in Microbiology and Immunology, 198, 121-130.
27. Russell, J.H. & Ley, T.J. (2002) Lymphocyte-mediated cytotoxicity. Annual Review of Immunology, 20, 323-370.
28. Schneider, E.M., Lorenz, I., Muller-Rosenberger, M., Steinbach, G., Kron, M. & Janka-Schaub, G.E. (2002) Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood, 100, 2891-2898.
29. zur Stadt, U., Kabisch, H., Janka, G. & Schneider, E.M. (2003) Rapid LightCycler assay for identification of the perforin codon 374 Trp→stop mutation in patients and families with hemophagocytic lymphohistiocytosis (HLH). Medical and Pediatric Oncology, 41, 26-29.
30. zur Stadt, U., Schmidt, S., Kasper, B., Beutel, K., Diler, A.S., Henter, J.I., Kabisch, H., Schneppenheim, R., Nurnberg, P., Janka, G. & Hennies, H.C. (2005) Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Human Molecular Genetics, 14, 827, February 9 [Epub ahead of print].
31. Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P.A., Henter, J.I., Bennett, M., Fischer, A., de Saint Basile, G. & Kumar, V. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286, 1957-1959.
32. Stepp, S.E., Mathew, P.A., Bennett, M., de Saint Basile, G. & Kumar, V. (2000) Perforin: more than just an effector molecule. Immunology Today, 21, 254-256.
33. Suga, N., Takada, H., Nomura, A., Ohga, S., Ishii, E., Ihara, K., Ohshima, K. & Hara, T. (2002) Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. British Journal of Haematology, 116, 346-349.
34. Sullivan, K.E., Delaat, C.A., Douglas, S.D. & Filipovich, A.H. (1998) Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatric Research, 44, 465-468.
35. Trapani, J.A. & Smyth, M.J. (2002) Functional significance of the perforin/granzyme cell death pathway. Nature Reviews Immunology, 2, 735-747.
36. Yoshida, N., Ishii, E., Oshima, K., Yanai, F., Ogawa, A., Kataoka, S., Sako, M., Park, Y.D., Koide, K., Imayoshi, M., Zaitsu, M., Muraoka, K., Hamasaki, Y., Imashuku, S. & Yasukawa, M. (2003) Engraftment and dissemination of T lymphocytes from primary haemophagocytic lymphohistiocytosis in scid mice. British Journal of Haematology, 121, 349-358.
37. Zamai, L., Ahmad, M., Bennett, I.M., Azzoni, L., Alnemri, E.S. & Perussia, B. (1998) Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. Journal of Experimental Medicine, 21, 2375-2380.